[{"title": "Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxQWmRsckdZSGZ4ak9zY0dmblhONDA2UWlwaEZBejZCQTR2aWN5dWZPVXp5MEkyRS1vNWk3UXFOb2RLdHRIeHEyZWRNTXhBcndZOXR4SmNnU3pOY3Azc3lvcUFMOXAyMDVRSFFGbnlyN3h5dGc3WG9Jak56VTNyV3RWU0VyZnE5Zw?oc=5\" target=\"_blank\">Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 12:26:00 GMT"}, {"title": "Novo Nordisk: Enough Is Enough (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTFA4bUtNeDNQamFYTnpYWGNwSTJnY01PdzdMejVjSzFDamhUWDhpcUpvbzdJZWZDdS1SVWJGa3ZJSzdmSEVsenJVelBXVFpTcXNWX1hQZFhVdmxBTmY2a0FPM0hGTHJXRjNIcHUxdVliMU5MNl9GajViWldR?oc=5\" target=\"_blank\">Novo Nordisk: Enough Is Enough (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 14:48:53 GMT"}, {"title": "Novo Nordisk\u2019s Wegovy Gets US Approval for Liver Disease - Bloomberg.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTEFVS3ZYV0VOX3VXaTg5X1ZZQkttSGMzWWt5UTVUWnpvLTgxellZM1BmUEZGQ1JwY1Z0aElwRlBKVm1ucUhvQlBFQUZ0Q0U4QUMtX1NBMWdSTkVuMUV2b3lqdGRYVDV3M1RVaU9zSkw3blctWVpzRU1KcTd5cE9tOXJwUzFqUUFMZzN2azUzTEExRC14blkwRzVOUVdGSWJoSndEcXdVc0xOdnM?oc=5\" target=\"_blank\">Novo Nordisk\u2019s Wegovy Gets US Approval for Liver Disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg.com</font>", "publishedAt": "Fri, 15 Aug 2025 22:54:33 GMT"}, {"title": "Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOdl9Tbl9CbFNlcU1tVC1xaWJhcWdwS2gzd0VnckR4dl80d0hReG1zRHVnNUFpa1ltWXMyY3VxTVdpOGdnajd5VDdyQ3NuUld2U3U4YjVuWk1VbkQ2WldoeG15MVgySXhQVUY3WkFPbC16bE9XMVljWkJxUUVJVy1tcGx1RnRHeDVBSEFXU3ZVRFQzZ0FKSDRFbjFONGtDVktSd2NNNDRhOWttMmx3M2d4ODd1dXNMemxjMjBXREE4ZTdoeVdMRktXWFpiRjlXVzF1LV81eGxhRFlROHU0?oc=5\" target=\"_blank\">Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 21:36:47 GMT"}, {"title": "NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar", "description": "<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxNeEtvV0NDZU00NXVYWTNSVmw0R2F5ZzMzMVNxNElVQmdma2FiYVBXUFBfLTZidmg5WWNmNm1JbGh5NFBlWnZCN1kwc3JDX2I1WGxaRHZxYXdWUTdxbGo2S0VEejlySlVXa1VGYXRpeTFXSHdnSlhGdjlhWnM0dkRQVlBCeHJGb1dVUUxHUHJEZkFuNkg5MXBlR2NGMkF3Tk9CVmVwSDh0Z2IzMjVKNDgxSGpaWlJzbDlOMWZfdXcyN1ZjVTFfcndFYUJ3ZFRsOTVFTkV4Smd0LXd4VUF3Y0lMcV9JTVJrR0hGOWg0OHF0OXI2cGtTT0hRb3JSVUhURlNlWGI5aHEyeWhQdDlx?oc=5\" target=\"_blank\">NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Morningstar</font>", "publishedAt": "Thu, 14 Aug 2025 12:45:00 GMT"}, {"title": "Here's Why Novo Nordisk (NVO) is a Strong Growth Stock - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTE1WRGJUcjNmdjFCbGduT3Y1QnI5LUNkTkZuMVlpNnh2a1N2WU85SVBmS0k2ZERUbVpZcnhseC1yQnV2akZWbmg4QlNncUZZeS1mVkRPa1RIRVVkYVFnNk5hTVFRN3J1WEtNY0VGUnhBVWcwVFhaMkJsN1JhcXg?oc=5\" target=\"_blank\">Here's Why Novo Nordisk (NVO) is a Strong Growth Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 13:45:02 GMT"}, {"title": "Novo Nordisk: Watching Value Investors Buy The Dip Hurts My Eyes (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNYUJCZzFQejdoNUtmeHgwYm9Ma192UmRTbUlzX2Jncm9iV1A1N0JrTlE4SEd0VnZzSHJmYjZDTktlUUdTUnJ2RE11ZFRaZC1xRmVFUzlJOW9xd2RxX0thaHZBTjVsUmstbUJFSUlpTDNTdmhYa3lYU1Eta3ZuZUZoVDVQT01iTS1RUGkzb1BNM1VyaldLOGdKM1dwSXpjVDNGc3JpVHlQYw?oc=5\" target=\"_blank\">Novo Nordisk: Watching Value Investors Buy The Dip Hurts My Eyes (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 15:51:36 GMT"}, {"title": "NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit - Morningstar", "description": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQakdoMWNQMFR5M0V2enU1Y2Vyb2RpMUl2UTFQcnBKLTRMbmJjOHQ2SmlxY2RZSXRrT2h5ZHFTQWVZcWYtbWs5bjRPeVNEeHRtaXF0RUFhejV0ZTZNOGFRX0hxNUdMWDZJRkRyQndLQWZfS2QxcFo2bFQxRkljbFJOUjRacGRRUjh1R3U3eUtxRlpQb2dwcjh1SWMwNjFUUFhzX1hTTUlHTVJrZ2tVTVV5R0hjU092UWJibmN1RlFKQk1lbnlQSFIwLUNLdU9KbVB3eUpzUlhoZw?oc=5\" target=\"_blank\">NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Morningstar</font>", "publishedAt": "Fri, 15 Aug 2025 20:45:00 GMT"}, {"title": "It's Time To Be All-In On Novo Nordisk (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPNE5ObU9TeE5XOWF6OWM5LWNzaElEQ2hqOC05b29wb2lWX1B1dG1wS2dLMERGRG1oTUdZMmxybDQxY1MtcXREeFhGN0lib3IzaWhSQW80MVpyeE03M1FVYWpVZlVKalBvaDlTcXdlQlhabDI1eEhIa3FaVFlFWDhFT1J1ZVY?oc=5\" target=\"_blank\">It's Time To Be All-In On Novo Nordisk (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Thu, 14 Aug 2025 14:50:58 GMT"}, {"title": "Novo Nordisk A/S: Wegovy\u00ae approved in the US for the treatment of MASH - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQbVpOeGpjMVdRdVZEaDVJNTJDR1hWeFYwYWxNYXhwMnNDdFI5QzdPVFVhSzBCZXVyZ2R1RGhUTHR2YlVoVFJjZi1pV3dtNXpnWjRDM2gyMnUyVFpjTG00NkdwR3N5dzhRVGpHSXR5QmUxbE9kcmFxOElzaGdUVEU1VGdoaw?oc=5\" target=\"_blank\">Novo Nordisk A/S: Wegovy\u00ae approved in the US for the treatment of MASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Fri, 15 Aug 2025 21:23:00 GMT"}, {"title": "Why I Tripled My Novo Nordisk Position (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxQYmpRVnZ3Uy1NY1hpTmdUYS1oeGVjT3NORmdqSWczYnNrcXlid25Fb2NhVHZTN0JCSVd5UGFsV0JXZ0t5dWtiNzF6bTNtZEFUdGlPZEhzV2dLdG9odHZSdi1EeUJvV2lPRWQ0amFSenFWaUVZQS1oMnQxLWhheEJiaGp5ZGRDUQ?oc=5\" target=\"_blank\">Why I Tripled My Novo Nordisk Position (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Sun, 10 Aug 2025 12:29:14 GMT"}, {"title": "Novo Nordisk Rises 6% So Far in August: How to Play the Stock - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTFBLc0JyNUVSVXU2N0Qybk5FQ2x2YlZVTTZFUlJjbXRmbDN4MFBySkxBY3VLV3hVcFVPVXlqUERiZmotZjRfdWJzYWtOVTJTSlR4R3ZlNm1MQi1lWVJ3TUNFaEN2Ylg4WFhZLTJ3NW11T1MzWjV3UXBaaFdR?oc=5\" target=\"_blank\">Novo Nordisk Rises 6% So Far in August: How to Play the Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Wed, 13 Aug 2025 14:47:00 GMT"}, {"title": "A Cure For Novo Nordisk (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiakFVX3lxTFBGaXFacXFNYWZCbFNUTWNtRnpXaW44dnlLaVFYOFpESW9aUVBKc1M4UXdYVXRtZE9vSEI1QWdXbGd4TXJSOTd3SzRsaXJUVEdNOGw5Ny1qeVU0dTBGcF8wczVqOTVpQkgzQ3c?oc=5\" target=\"_blank\">A Cure For Novo Nordisk (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Wed, 13 Aug 2025 17:34:41 GMT"}, {"title": "Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObldUU2FETTF1cmtSWVBoZGV3U3lWNmdmdEdrcmJ0NXFYUWZLSWFQN0Q3ckNGQ1JKVEFvZVlfVmltcVRBWnh5TDJBZFI1Vm5wQ0tacXVWZUE0aVY0SFRFcGNUSlJOd3VLUEZsUnQ5amo3VC1qTzh3Zk9tOXZwcnh5TnFNcTQ3dw?oc=5\" target=\"_blank\">Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Wed, 13 Aug 2025 20:30:00 GMT"}, {"title": "Novo Nordisk: The Falling Knife That Keeps Giving - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOV2Y1SzhmT2NWVHp5bmJ1TE5uaXVCRnNuLXh2Rl9zdlMwTzRxajJoX0xfWkJLNFQzYzEteGdvcjFiZkVoM3E5cVY5YzlVTF9pUUxZUk8tSlNLb2FnWlF0ZmhBdzJvWG54OHlOT2IzclNSN2JhYllrLWl6ei1HcWdEX0x4VHdHOWNTUWdlQTZn?oc=5\" target=\"_blank\">Novo Nordisk: The Falling Knife That Keeps Giving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Wed, 13 Aug 2025 15:14:29 GMT"}, {"title": "BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQYkJVWVRHWjl0cXIwMlNydE82Z3laV25Cc0stVVV1ZFFpcnNuYzh3M2VXWmphZDBOYlprLVNQbWhydlNsc3p3aG04TTFFOHp1VFVIRktUdTVpcFlaME5xSnRRRVY3LURaMlFJeUlvR3hLNzdRQTlyb2hyY3VfWERHZ29uaw?oc=5\" target=\"_blank\">BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Sat, 16 Aug 2025 02:15:42 GMT"}, {"title": "Novo Nordisk Reduces Sales And Operating Profit Outlook For 2025 - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNVnI5ZGV5dnFzREEtWklnVFVVLU1iT2hna2xVX3Z2RG53Ti1mcUJTTkJlVzQtUGt1MXVsZjRjbTJLTEY3UVJIR0FXTjNrOExBU0Z4QkRXUHRmNk1RaERZNWo5WkNFYy1mYkdDRWlFeFlnUHFSTHBfMVI3N2gyY0I1NE41bXlDT3FkSnc?oc=5\" target=\"_blank\">Novo Nordisk Reduces Sales And Operating Profit Outlook For 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 00:23:42 GMT"}, {"title": "HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTFBOSnhMeW1ZSUtoOWtJdkFISEFwNnhwcEdDQjA4blBpc1pROGFtcHVFS0Y5SUVyWUFkaFBNdmpETXU3ZmY3NkFWMkRvaDVHc3c2NUhYOV9PWkRKZEFoUGp5MFNjeWxlSEd0V29JUnJrOUZ0MmFPYnJoWVNFUS1VekE?oc=5\" target=\"_blank\">HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Wed, 13 Aug 2025 19:32:32 GMT"}, {"title": "Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave? - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQTllZVF9ZelhVZWw1bUNkQklza3ViX0hGbmZjamxvZWVUM01yWkpkdElrVXNhRkk1QkYwZ2FtY2gzcDU1amJ1NmlDRGhhX1h5eG9TX2YtNmxydmJpbFFCb0JXVHNCWGhMdlFUZGw3QTdtOEU0TFloV3pZa3hOUk1yTDNhZmxYVXhGZ1E?oc=5\" target=\"_blank\">Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Fri, 15 Aug 2025 13:06:00 GMT"}, {"title": "The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQV1RVWmI0YjJoUklDMmxidkQ3X05leWVDSVV2MFo5ZzJUcm1hOU5ucm9kUk1hUVRYWGdRZUhBTEl6LW80aW1ScmF4M1dEWS1JNmF0OU1ickVvZW5rZGNvU0tqdXRRdjI0RDdsbi0zSEs5NDRXcHg2bjIzeWdTNFFlTXhjRUhGcl9XTkE?oc=5\" target=\"_blank\">The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 15:10:00 GMT"}, {"title": "Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMizwFBVV95cUxPdjJsTWVsU3ZKU1RBYzFscFdvR0F4UWxPYUhfS1BPQjhqSWw4SjAybVNCbnJDczdOTmNSTldpdXZjZm1DS1VaVEVMYjB3TXdwcEY2bzEwYTRFXzhUUWtxRjBkeVRPOUltWl9hYmFnbnktaXJOOVBLVnI0dFUyUzhOMGxrLUxEMHdkdVpYcExtLWp6WHcwVEdCR0R2SDJ2bDV1ZDZUTTBoWmtPS0lZclZlRVUwQVFqRUNEZmtrbF9SMTFvTjB3Sm1Xd2lXODczZ1E?oc=5\" target=\"_blank\">Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Sat, 16 Aug 2025 13:00:33 GMT"}, {"title": "Investors in Novo Nordisk A/S Should Contact Levi & - GlobeNewswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMikAJBVV95cUxOalRFMkdvc0JadVNRWFNvVERHdDMwRm53U3Z6VmRTVzItNF94RjVuSUhtcTdTUTFNMWdZaFk1dDlEWE8xOXhFRnZ1czdLemdBc1pRejdlOEhOYlBGVFctQWlsaElYYnlrVjF3cWpQSGZIOUk0S3JFQ0xfSEJMNEtjUW1CYTNUNXZJRnM4d25uY2FzSm5VaHJKTEg5ano5X25KY2xJNVBjYWdkd1FvTzFUNk5IVWVJRTBfYVEwV2FLNHIyVEw0UjRZX2dpazZuOGxhdUNvZlRiaXdmSnlkN1otT3V0YnBuSDlzRU9fajhDYWxfbURoQmY0X3JJNGhwRlJ1bGlUY19lQXhwdHZoZFV6Yg?oc=5\" target=\"_blank\">Investors in Novo Nordisk A/S Should Contact Levi &</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GlobeNewswire</font>", "publishedAt": "Thu, 14 Aug 2025 20:42:26 GMT"}, {"title": "BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform - MSN", "description": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxOcm1qRkZnZGVJRW1HQ1JSaDdtTTQyVy0wbVZZVFFxOWE1YXVmRnZUeTZaa1c3Rjh2bm1Qb0dDUWVmUEZuTVFUUkdweFRKV3R2MjhRWFdndm1lWGh0TmNYbWZjbWxBMXVocE5rZ1RNVXFHdjNkaEE3WjVXZU1FQWNfYzlrOTNEVlBYWllWdTdxNG9CMFlVNWJ6SWlEemZZN1lDTUJ5QUk5LXA0QmFZR3F5N1ZyTXBtQXQ0U3NEOVRRZWgxOFZJ?oc=5\" target=\"_blank\">BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>", "publishedAt": "Sat, 16 Aug 2025 02:39:20 GMT"}, {"title": "NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgJBVV95cUxOVkVHSC1HTC10cWhtZUEwOFg0Vk9Pa01GUTFMOEt5YUNRbGdwblA3UUhBZDhBMUVxSldaQ2E0cmJUSFJhQ1g2WjJWY1VuTEVrN0lHMG5BSi1BYVAzeExwanMtQVoyaEFJTXJDZE5fUkdNZkV0blZCYWtTai1MWHUtVlgtNzAwNXh0aU5yOGx3NFVoSnQ3NEhlVS1SZkNETzlHOUJCT0tzU3NHMnFiS19rTnZLQ0h1NWFlTHdiUTFxVlFsT09DajR0TzlhRDh4LWpKcDdQbHVFOUwwWmNnbmlnZGljUzhlRDBNRFYweWxCQUJuaDJLcU5ObVpWbk9nc1NQbDBoalRn?oc=5\" target=\"_blank\">NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>", "publishedAt": "Thu, 14 Aug 2025 12:45:00 GMT"}, {"title": "Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO - Morningstar", "description": "<a href=\"https://news.google.com/rss/articles/CBMiowJBVV95cUxQMVJ3eG03SUI0dENWYjFMeVk0SEVFRUFpNW53c3dORzc2WUdWdndITEQtR1c4N215ajdMZktEakQxWHEtLThEV1UzNGtJalpGODhYNXFuU1JGUjA1WTlGd1ByVWhpcmFRTkJSN1BUMmRpOWttYk9zMTQ5WWtaYWhSWmh4UG1iUU9abV9KUm1mRHdYczY3WE4yZmhLWVNGZU1ocDA5eXBrM2FfYmVXaGRBeHh5aVlCeUxQUzJXNTROZlBNckVzQ2JxSi0weEV4Sjd0WHJRWkdpYkt6MnhHSmZHUmwyaWlnQmI2clBkdWk4UjhvNDdaREFhbExDN05pYXVqMGpsdW9rcldtZVlDUTIxeE5yd0tWNWlxa1U3bGVQTnN5dWc?oc=5\" target=\"_blank\">Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Morningstar</font>", "publishedAt": "Fri, 15 Aug 2025 16:14:00 GMT"}, {"title": "Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOOHVRV2UzVW13ZTBqZXBsVl94WjVZRk1aenZOUVdQZ0VlbG8xVm9pYXVtMGRjZDFvYTNOSUlXMTZDZ0hkU2ZIeFhsNUNKOGw1bTI3bVp2d3lERl9LZ1pWb1R6Mnprd0V3LUVRakxsQ2ZIWUpseTBIREtReTM4dmJzM0hGTm9mV01qZk1R?oc=5\" target=\"_blank\">Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Sat, 16 Aug 2025 11:01:57 GMT"}]